TissGeneSummary for TREX2 |
Gene summary |
Basic gene information | Gene symbol | TREX2 |
Gene name | three prime repair exonuclease 2 | |
Synonyms | - | |
Cytomap | UCSC genome browser: Xq28 | |
Type of gene | protein-coding | |
RefGenes | NM_080701.3, NM_080699.2,NM_080700.2, | |
Description | 3'-5' exonuclease TREX2 long form | |
Modification date | 20141207 | |
dbXrefs | MIM : 300370 | |
HGNC : HGNC | ||
Ensembl : ENSG00000183479 | ||
HPRD : 02299 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_TREX2 | |
BioGPS: 11219 | ||
Pathway | NCI Pathway Interaction Database: TREX2 | |
KEGG: TREX2 | ||
REACTOME: TREX2 | ||
Pathway Commons: TREX2 | ||
Context | iHOP: TREX2 | |
ligand binding site mutation search in PubMed: TREX2 | ||
UCL Cancer Institute: TREX2 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Skin | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | SKCM | |
Reference showing the relevant tissue of TREX2 | ||
Description by TissGene annotations | Cancer gene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0000738 | DNA catabolic process, exonucleolytic | 11279105 | GO:0006259 | DNA metabolic process | 11279105 | GO:0000738 | DNA catabolic process, exonucleolytic | 11279105 | GO:0006259 | DNA metabolic process | 11279105 |
Top |
TissGeneExp for TREX2 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KIRC | 1.262187629 | -0.371224871 | 1.6334125 | 6.29E-09 | 1.94E-08 |
Top |
TissGene-miRNA for TREX2 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for TREX2 |
TissGeneSNV for TREX2 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.L234M | KIRP | 1 |
p.R156H | UCEC | 1 |
p.D272N | BLCA | 1 |
p.D123Y | DLBC | 1 |
p.L74I | STAD | 1 |
p.R99W | LGG | 1 |
p.A28T | HNSC | 1 |
p.S185N | UCS | 1 |
p.C30R | UCEC | 1 |
p.R24H | BLCA | 1 |
p.R37H | READ | 1 |
p.R37P | LIHC | 1 |
p.V56I | UCEC | 1 |
p.E191K | HNSC | 1 |
p.T61M | PAAD | 1 |
p.R12H | PRAD | 1 |
p.V8I | STAD | 1 |
p.R156L | BRCA | 1 |
p.D89N | CESC | 1 |
p.P9L | SKCM | 1 |
p.S81N | UCEC | 1 |
p.G5E | UCS | 1 |
p.R37L | ACC | 1 |
p.R207L | LUAD | 1 |
p.V97M | GBM | 1 |
p.D230N | BLCA | 1 |
p.R24S | PRAD | 1 |
p.L30V | LUAD | 1 |
p.T104M | PAAD | 1 |
p.R37H | LIHC | 1 |
p.R165L | LUAD | 1 |
p.P9S | SKCM | 1 |
p.R137P | LUAD | 1 |
p.R87* | UCEC | 1 |
p.R165W | LUAD | 1 |
p.E235A | DLBC | 1 |
p.V97M | UCEC | 1 |
p.R37C | STAD | 1 |
p.R79C | STAD | 1 |
Top |
TissGeneCNV for TREX2 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for TREX2 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | X99270 | TREX2-NRXN1 | chrX:152730496 | chr2:51083187 |
Top |
TissGeneNet for TREX2 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for TREX2 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for TREX2 |
TissGeneDrug for TREX2 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for TREX2 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0011853 | Diabetes Mellitus, Experimental | 1 | RGD |
umls:C0024141 | Lupus Erythematosus, Systemic | 1 | BeFree,GAD |
umls:C0033578 | Prostatic Neoplasms | 1 | LHGDN |